TCTR20151118005招募中未知
Optimal dose of protamine for heparin reversal in cardiopulmonary bypass surgical patient
Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 500 人开始时间: 2015年11月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Underwent cardipoulmonary bypass surgery
排除标准
- •1.Renal failure
- •2.Liver failure
- •3.Redo surgery
- •4.Endocarditis
- •5.Thoracic aortic aneurysm
- •6.Cyanotic heart disease
- •7.Preoperative use anticoagulant
- •8.Use intraoperative or postoperative of intra-aortic balloon pump (IABP) or extracorporeal membrane oxygenation (ECMO)
- •9.Heparin resistance
- •10.Intraoperative death
- •11.Use total circulatory arrest technique
- •12. Incomplete data
研究者
相似试验
已完成
4 期
Optimal Protamine Dosing for Heparin Reversal Following Cardiopulmonary BypassIntravascular CoagulationNCT05426031University of Miami130
尚未招募
不适用
Effect of heparin reversal by protamine sulfate on the outcome of thrombolysis in acute ischemic stroke after percutaneous coronary interventioNervous System DiseasesPACTR202109714591017neurology department ain shams university60
尚未招募
1 期
comparision of different protamine to heparin dosing strategies in cardiac surgeries requiring cardio pulmonary bypassCTRI/2021/02/031467Balabhadra Sai Priyanka
已完成
不适用
Heparin Reversal With Two Different Protamine Ratios After Cardiopulmonary By-pass.Cardiac SurgeryCADValve Heart DiseaseCoagulation DisorderNCT06154018University of Ioannina98
Unknown
不适用
Systematic Evaluation of Protamine Doze in Cardiac SurgeryCardiac Surgery With Cardiopulmonary BypassNCT03787641Lawson Health Research Institute100